Angiofibroma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) (NCT02635789) | Nobelpharma | 2015-12-01 |
| Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex (NCT02634931) | Nobelpharma | 2015-12-01 |
| Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) (NCT01031901) | The University of Texas Health Science Center, Houston | 2009-12-01 |
Track Angiofibroma automatically
Every clearance here is in the API, with alerts when new ones post.